Pharmacokinetic and pharmacodynamic study comparing two different dosages of Thymoglobuline in renal transplantation

Trial Profile

Pharmacokinetic and pharmacodynamic study comparing two different dosages of Thymoglobuline in renal transplantation

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Sep 2013

At a glance

  • Drugs Antithymocyte globulin (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacodynamics; Pharmacokinetics
  • Acronyms THYMO
  • Most Recent Events

    • 08 Sep 2013 Results presented at the 16th Congress of the European Society for Organ Transplantation.
    • 08 Sep 2013 Status changed from recruiting to completed.
    • 14 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top